SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea

OBJECTIVE: This pivotal phase III study, SIAXI, investigated the efficacy and safety of incobotulinumtoxinA for the treatment of chronic sialorrhea due to Parkinson disease (PD), atypical parkinsonism, stroke, or traumatic brain injury (TBI). METHODS: Adult patients with PD (70.7%), atypical parkins...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurology
Autors principals: Jost, Wolfgang H., Friedman, Andrzej, Michel, Olaf, Oehlwein, Christian, Slawek, Jaroslaw, Bogucki, Andrzej, Ochudlo, Stanislaw, Banach, Marta, Pagan, Fernando, Flatau-Baqué, Birgit, Csikós, János, Cairney, Claire J., Blitzer, Andrew
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511076/
https://ncbi.nlm.nih.gov/pubmed/30918101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007368
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars